baber/WOPTO huggingface dataset:
Patent AU-630656-B2 (AU)
Title: Process for hydrophobic polymer surfaces
Inventor: JANSSEN ROBERT A
IPC: C08J7/00
Filed: 1990-01-12
Granted: 1992-11-05
Abstract: Process for treating hydrophobic polymer surfaces to form hydroxyl moieties thereon comprises ozonating the surface of said hydrophobic polymer to form hydroperoxy groups thereon, and then irradiating said ozonated surface with ultraviolet light or exposing to heat to convert the hydroperoxy groups to hydroxyl moieties in the presence of a hydrogen donor. Such hydroxylated surfaces possess hydrophilic properties and can undergo the chemical reactions characteristic for hydroxyl groups. Polymers so modified are useful in biomedical devices, semipermeable membranes, films, fibers and especially contact lenses.
Patent AU-765602-B2 (AU)
Title: Photostable sunscreen compositions containing dibenzoylmethane derivative, e.g.,parsol® 1789, and diesters or polyesters of naphthalene dicarboxylic acid photostabilizers and enhancers of the sun protection factor (SPF)
Inventor: BONDA CRAIG A
IPC: A61K8/31
Filed: 1999-07-06
Granted: 2003-09-25
Abstract: A hair-treating composition containing a diester or polyester of a naphthalene dicarboxylic acid having compound formula (I) or (II), or mixtures; for imparting gloss and/or hair color stabilization:wherein each R1, same or different, is an alkyl group having 1 to 22 carbon atoms, a diol having the structure HO-R2-OH, or a polyglycol having the structure HO-R3-(-O-R2-)m-OH, wherein R2 and R3, same or different, are each an alkylene group, sight chain or branched, having 1 to 6 carbon atoms, and wherein m and n are each 1 to about 100, or a mixture thereof. These diesters and polyesters of formula (I) or (II) are quite effective in stabilizing the dibenzoylmethane derivative UV-A filter compounds making them more effective, and effective for longer periods of time.
Patent AU-623502-B2 (AU)
Title: Use of inhaled loop diuretics for treating allergen-induced nasal reactions
Inventor: BIANCO SEBASTIANO
IPC: A61K31/341
Filed: 1990-03-07
Granted: 1992-05-14
Abstract: High-ceiling diuretics, especially the known furosemide, are effective medicines for the treatment of allergen-induced nasal reactions when solutions thereof are atomised into the nostrils. <IMAGE>
Patent AU-531434-B2 (AU)
Title: Self-curing polyalkylacrylate composition
Inventor: SEIDEL HARTMUT
IPC: C08F265/06
Filed: 1979-09-26
Granted: 1983-08-25
Abstract: Self-curing compositions are prepared based on polymethyl methacrylate (PMMA) are by mixing a finely powdered solid polymer phase of PMMA and/or poly (2-hydroxyethyl methacrylate) (PHEMA) with a liquid monomer phase of methyl methacrylate (MMA) and/or 2-hydroxyethyl methacrylate (HEMA) in a weight ratio of polymer phase to monomer phase of 1.5 to 3.3:1 wherein the portion of PHEMA in the cured product is between 2 and 99 weight %. The product is prepared by vigorously stirring the mixture at room temperature until the polymerization is essentially finished.
Patent AU-618884-B2 (AU)
Title: Process for the production of hydrogen cyanide
Inventor: SHERWIN MARTIN BARRY
IPC: C01C3/02
Filed: 1990-03-23
Granted: 1992-01-09
Abstract: A process for the production of hydrogen cyanide which comprises combining methanol ammoxidation with formamide decomposition in the same reactor, using a metal oxide catalyst. This process generally involves forming a gaseous reaction mixture comprising methanol, formamide, ammonia, oxygen and optionally formaldehyde. This reaction mixture is then passed over the metal oxide catalyst at a temperature in the range 200 DEG  to 600 DEG C and a pressure in the range 5 to 20 psig.
Patent AU-723219-B2 (AU)
Title: Optical array converting UV
Inventor: KUKLINSKI JAN
IPC: G02B5/20
Filed: 1997-12-29
Granted: 2000-08-24
Abstract: An optical array containing a system of absorptive filters and a system of interference filters. For the sun light the spectral characteristics of transmission of the optical array is close to the world-wide accepted Diffey Standard. That standard models human skin sensitivity to UV burning. The invention allows making inexpensive, miniature UV sensors that can be applied in a miniature devices measuring burning power of UV contained in the sun light.
Patent AU-626673-B2 (AU)
Title: Gastrostomy tube
Inventor: PIONTEK CARL JOSEPH
IPC: A61M25/00
Filed: 1990-05-14
Granted: 1992-08-06
Abstract: A replacement gastrostomy tube device (10) is provided comprising a catheter shaft (1) having an outer surface wall (13), with the shaft enclosing a feeding lumen (14) of substantially circular cross-section and a fluid flow channel (16). A port housing (18) is located at the proximal end of the shaft with the port housing having a main food inlet port (20), a Y-port (23) and a fluid inlet port (25). Near the distal end of the tube are an expandable component member (38) and a food outlet port (30), which port is preferably located at the distal end. The feeding lumen is of a greater diameter than that of the fluid flow channel. The outer surface wall is of a non-circular cross-section. The feeding lumen is of a circular cross-section which permits the passage therethrough of a jejunal tube. The main food inlet port is of a greater diameter than that associated with the Y-port. The method for using this device permits jejunal feeding through a replacement gastrostomy tube without retraumatizing the patient.
Patent AU-664939-B2 (AU)
Title: Process for the synthesis of semi-synthetic glycosaminoglycans with heparin or heparan structure modified in position 2 of the alpha-L-iduronic-2-O-sulfate acid
Inventor: UNGARELLI FABRIZIO
IPC: C08B37/10
Filed: 1994-02-10
Granted: 1995-12-07
Abstract: A process for the synthesis of semi-synthetic glycosaminoglycans of general formula III <CHEM> with heparin or heparan structure modified in position 2 of the alpha -L-iduronic-2-O-sulfate acid in which the sulfate group is, entirely or in part, substituted with a nucleophilic radical is described. Said process is carried out by treating glycosaminoglycans with heparin or heparan structure by means of a nucleophilic agent in alkaline medium.
Patent AU-593554-B2 (AU)
Title: Method and circuit apparatus for checking the authorization of access to a signal processing system
Inventor: WURZENBERGER JOHANN FRANZ
IPC: H04L29/06
Filed: 1986-05-27
Granted: 1990-02-15
Abstract: For checking authorization of access to a signal processing system (SVS) from designated peripheral units (TE, BS) connected with the system, for the purpose of transmitting and, if the occasion arises, receiving signals, it is provided that a keyword is entered in the signal processing system for each peripheral unit. Such a keyword is always derived from a code number allocated to a respective peripheral unit and from identification data which is freely selectable for the respective peripheral unit. In the event of an intended access by a peripheral unit, the code number transmitted by said peripheral unit and the identification data pertaining thereto are combined with the keyword allocated to the respective peripheral unit.
Patent AU-619127-B2 (AU)
Title: Burnishing method and composition
Inventor: ZOBBI ROBERT G
IPC: C23F3/00
Filed: 1990-08-07
Granted: 1992-01-16
Abstract: A burnishing liquid used in a physicochemical mass finishing process serves to chemically remove the conversion coating as well as to promote brightness of the treated metal surface. The burnishing liquid has a very low content of organic constituent and therefore a low chemical oxygen demand characteristic. The burnishing liquid comprises a water-soluble tetrapyrophosphate or hexametaphosphate and has a pH of about 8.5 to 10.5.
Patent AU-747981-B2 (AU)
Title: Device for discriminating a circular plate body
Inventor: OHTOMO HIROSHI
IPC: G07D5/00
Filed: 1998-04-14
Granted: 2002-05-30
Abstract: A device for discriminating a circular plate body, which device comprises:   a passage means adapted to guide and allow a circular plate body to orient vertically and fall naturally therewithin; a first coil means wound around the passage means; second and third core means each of which covers a respective opposing side of the first coil means; and second and third coil means, each wound around a respective one of said second and third core means.   <IMAGE>
Patent AU-764520-B2 (AU)
Title: Matrix-targeted fusion polypeptides for tissue regeneration and wound healing
Inventor: HALL FREDERICK L
IPC: A61K35/12
Filed: 2000-07-21
Granted: 2003-08-21
Abstract: The present invention relates to compositions and methods for promoting tissue repair and regeneration. The invention provides a fusion polypeptide useful for targeting tissues for regeneration and methods of use therefore.
Patent AU-633612-B2 (AU)
Title: Improved process for cyclic amino acid anticonvulsant compounds
IPC: C07C227/22
Filed: 1990-08-22
Granted: 1993-02-04
Abstract: An improved process for the preparation of cyclic amino acids by a novel synthesis is described where a dinitrile derivative is converted in two steps to the desired products, as well as valuable intermediates used in the process.
Patent AU-707098-B2 (AU)
Title: Multi-color overprinting of scratch-off lottery tickets
Inventor: DESBIENS JEAN-PIERRE
IPC: A63F3/06
Filed: 1996-06-04
Granted: 1999-07-01
Abstract: A method of producing a lottery ticket and lottery tickets produced thereby wherein an overprint region is provided over at least a scratch-off layer, the overprint region comprising an image obtained from a design in which the colors in the design have been separated into half tone images of each color and are superimposed on at least the scratch-off layer of the lottery ticket.
Patent AU-694419-B2 (AU)
Title: Crystalline ceftiofur free acid
Inventor: DUNN MICHAEL J
IPC: A61P31/12
Filed: 1994-03-07
Granted: 1998-07-23
Abstract: PCT No. PCT/US94/01862 Sec. 371 Date Sep. 11, 1995 Sec. 102(e) Date Sep. 11, 1995 PCT Filed Mar. 7, 1994 PCT Pub. No. WO94/20505 PCT Pub. Date Sep. 15, 1994Anhydrous and crystalline free acid form of the cephalosporin antiobiotic ceftiofur, processes for its manufacture, and pharmaceutical composition containing it are provided.   <IMAGE>
Patent AU-630755-B2 (AU)
Title: Sugar beet pectins and their use in comestibles
Inventor: WEIBEL MICHAEL K
IPC: A23L1/308
Filed: 1990-10-30
Granted: 1992-11-05
Abstract: Sugar beet pectins are provided, which are characterized by unique properties which render them particularly useful in the preparation of food or drug comestibles. By incorporating the sugar beet pectins into food or drug products, improved properties, including physicochemical, rheological and nutritional properties are obtained.
Patent AU-650860-B2 (AU)
Title: Nonwoven fabrics for printing
Inventor: UMEZU NORIO
IPC: D06P5/00
Filed: 1991-02-08
Granted: 1994-07-07
Abstract: A nonwoven fabric, particularly composed by long-stock synthetic resin yarns such as polyethylene and polypropylene is provided at one or both surfaces thereof with an ink-setting layer formed by coating, drying and curing a resin composition containing some of acrylic resins, synthetic rubbers and polyester resins. The ink-setting layer is excellent in the transfer property and fixing ability to an oil ink which is ordinarily used for offset printing, and prevents the nonwoven fabric from being swelled or transformed by a petroleum high-boiling-point solvent contained in the oil ink. Preferably, a low-temperature cross-linking agent is incorporated with the resin composition of the ink-setting layer so as to complete cross-linking of the resin composition at a low temperature at which heat shrinkage or heat damage of the nonwoven fabric will not be caused, in a shortened period of time. Moreover, when 10 to 40% by weight of non-calcined clay, 1 to 15% by weight of titanium dioxide and 1 to 10% by weight of calcium carbonate or calcined clay are incorporated as fillers in the resin composition of the ink-setting layer, the ink-setting layer has improved absorbability, drying ability and fixing ability to a printing ink. A preferable construction of the nonwoven fabric has a first layer containing the low-temperature cross-linking agent and a second layer containing the specific filler ingredients.
Patent AU-728151-B2 (AU)
Title: Novel cyclic diamine compounds and medicine containing the same
Inventor: SHIBUYA KIMIYUKI
IPC: C07D417/14
Filed: 1998-05-26
Granted: 2001-01-04
Abstract: The present invention offers novel cyclic diamine compounds and a pharmaceutical composition containing the same. The present invention relates to a compound represented by the formula (I) or salt(s) or solvate(s) thereof. <CHEM>  (In the formula, <CHEM> is an optionally substituted divalent residue of benzene, pyridine, cyclohexane or naphthalene or is a vinylene group where     Ar is an optionally substituted aryl group;   X is -NH-, oxygen atom or sulfur atom;   Y is -NR1-, oxygen atom, sulfur atom, sulfoxide or sulfone;   Z is a single bond or -NR2-; R1 is hydrogen atom, optionally substituted lower alkyl group, optionally substituted aryl group or optionally substituted silyl lower alkyl group; R2 is hydrogen atom, optionally substituted lower alkyl group, optionally substituted aryl group or optionally substituted silyl lower alkyl group;   l is an integer of from 0 to 15;   m is an integer of 2 or 3; and   n is an integer of from 0 to 3).   The compound of the present invention is useful as a pharmaceutical composition, particuarly as an inhibitor of acyl coenzyme A cholesterol acyltransferase (ACAT).
Patent AU-641493-B2 (AU)
Title: Recombinant herpesviruses in particular for the production of vaccines, their preparation process, plasmides produced during this process and the vaccines obtained
Inventor: REY-SENELONGE ARIELLE
IPC: C12N15/869
Filed: 1991-03-07
Granted: 1993-09-23
Abstract: PCT No. PCT/FR91/00184 Sec. 371 Date Jan. 3, 1992 Sec. 102(e) Date Jan. 3, 1992 PCT Filed Mar. 7, 1991 PCT Pub. No. WO91/13995 PCT Pub. Date Sep. 19, 1991.The recombinant virus chosen from the turkey herpesvirus(HVT), Aujeszky's disease virus (PRV), infectious bovine rhinotracheitis virus (BHV) feline infectious rhinotracheitis virus (FHV), equine rhinopneumonia virus (EHV), canine herpesvirus (CHV), duck herpesvirus, human simplex herpesvirus (HSV), varicella virus (VZV), Epstein-Barr virus (EBV), cytomegalovirus (CMV), comprises at least one heterologous gene, coding particularily for a viral, bacterial or parasitic immunogen inserted in the region of the genome of the said virus corresponding to the gene of the small sub-unit RR2 of ribonucleotide reductase so that it may be expressed. The method for preparing a virus of this type involves inserting the heterlogous gene into the said region of the genome, particularly after partial or total deletion of this region. The recombiant virus obtained may be used particularly for preparing living vaccines. The small sub-unit of the ribonucleotide reductase of the turkey herpesvirus (HVT) has been sequenced.
Patent AU-656890-B2 (AU)
Title: Coating compositions
Inventor: O'KEEFFE LUKE JAMES
IPC: C09D167/00
Filed: 1991-03-26
Granted: 1995-02-23
Abstract: A thermosetting powder coating composition according to the present invention comprises as binder a co-reactable particulate mixture of a carboxylic acid-functional polyester component and a curing agent having groups reactive with carboxylic acid groups, characterized in that the carboxylic acid-functional component comprises a semi-crystalline polyester having an acid value of from 10 to 70 mg KOH/g and a hydroxy value of no more than 11 mg KOH/g. Generally the semi-crystalline polyester has one or more Tg values less than 55 DEG C, a sharp melting point of 50 to 200  DEG C and preferably a number average molecular weight of at least 1600. The composition may, if desired, include an amorphous polyester and the curing agent may be, for example, an epoxy resin or a bis(beta-hydroxyalkylamide). Coating compositions of the invention cure faster than in the absence of semi-crystalline polyesters and the thermoset coatings prepared therefrom have improved appearance and mechanical properties (especially flexibility).
Patent AU-783118-B2 (AU)
Title: Methods related to immunostimulatory nucleic acid-induced interferon
Inventor: HARTMANN GUNTHER
IPC: A61P1/08
Filed: 2000-09-27
Granted: 2005-09-29
Abstract: Methods and compositions are provided for extending the clinical utility of IFN- alpha  in the treatment of a variety of viral and proliferative disorders. Among other aspects, the invention provides methods which increase the efficacy of IFN- alpha  treatment and reduce IFN- alpha  treatment-related side effects. In addition, methods are provides for supporting the survival and for activating natural interferon producing cells (IPCs)<i>in vitro</i> without exogenous IL-3 or GM-CSF. The invention is based on the discovery that certain CpG and non-CpG ISNAs promote survival and stimulation of IPCs.
Patent AU-559294-B2 (AU)
Title: Stabilisation of water-bearing explosives
Inventor: SANDELL LIONEL SAMUEL
IPC: C06B47/04
Filed: 1982-01-12
Granted: 1987-03-05
Abstract: Water-bearing explosives comprising oxidizer, fuel, and sensitizer components in a thickened or gelled continuous aqueous phase are stabilized against the degradation of their thickened or gelled structure by the incorporation therein of iodide and/or iodate ions. Preferably, iodide ion is introduced by dissolving ammonium iodide or an alkali metal iodide in an aqueous liquor or sol containing the oxidizer component. The stabilization method is particularly useful in explosives containing a guar gum thickener and flake aluminium in the sensitizer component.
Patent AU-613586-B2 (AU)
Title: Chemiluminescent acridinium salts
Inventor: MATTINGLY PHILLIP GREGORY
IPC: G01N33/52
Filed: 1987-10-15
Granted: 1991-08-08
Abstract: Acridinium sulfonylamides and isomers, such as phenanthridinium sulfonylamides, may be employed in applications including chemiluminmescent immunoassays. Methods for synthesis of these compounds include contacting an amine with a sulfonylhalide to form a sulfonamide and acylating with an activated carboxylic acid of an acridine or isomer thereof. The N-sulfonyl-9-acridinium carboxamide and isomer may be conjugated to antigens, haptens, antibodies, and nucleic acids for use in chemiluminescent assays.
Patent AU-597136-B2 (AU)
Title: Method for preparing crystalline cefadroxil monohydrate
Inventor: MARSILI LEONARDO
IPC: C07D501/22
Filed: 1987-12-24
Granted: 1990-05-24
Abstract: The invention relates to a method for preparing crystalline cefadroxil monohydrate. According to such a method a cefadroxil solvate is slurried with isopropyl alcohol containing less 6% to 18% W/W of water at a temperature between + 45 and +55 DEG C: the crystalline cefadroxil monohydrate is isolated by filtration. Some of the cefadroxil solvates which can be used are novel: they are prepared by adding dimethylacetamide, N-methyl-2-pyrrolidone or monomethylformamide to an aqueous solution of cefadroxil at a pH between 5.5 and 6.
Patent AU-651624-B2 (AU)
Title: Enhancement of glutathione levels with glutamine
Inventor: WILMORE DOUGLAS W
IPC: A61K31/198
Filed: 1991-09-11
Granted: 1994-07-28
Abstract: A method of maintaining and/or enhancing tissue or plasma levels of glutathione is provided. Treatment of a mammal with a supranormal amount of glutamine, or a glutamine equivalent, prevents the reduction in tissue glutathione levels associated with exposure of the mammal to a compound capable of oxidative injury to the tissue. Such compounds may be drugs such as chemotherapeutic agents. Administration of a supranormal amount of glutamine or a glutamine equivalent after exposure of a mammal to a compound capable of oxidative injury to the tissue can ameliorate or prevent injury. Treatment of a mammal with glutamine or a glutamine equivalent can also reduce or prevent starvation- or radiation-associated oxidative damage in the tissues.
Patent AU-645360-B2 (AU)
Title: Ear-protection cup for ear muffs or headphones
Inventor: LUNDIN RUNE
IPC: A42B3/16
Filed: 1991-10-31
Granted: 1994-01-13
Abstract: An ear-protection cup (1) for ear muffs or headphones comprising a cup-shaped frame and a resilient sealing member (5) located at the peripheral edge (4) thereof, by means of which the ear-protection cup (1) can be brought into abutment with an annular shaped part of a user's head located around the ear. The frame is composed of a rigid, cup-shaped outer shell (2) and an inner wall (6, 7) spaced from the outer shell (2) and extending for a substantial way between the inner parts of the outer shell (2) to which it is rigidly connected. The inner wall (6, 7) thus defines between itself and the outer shell (2) an intermediate space (12) in which a layer (13) of elastomeric material is arranged compressed between the outer shell (2) and the inner wall (6). <IMAGE>
Patent AU-558254-B2 (AU)
Title: Imidazolecarboxylic acid derivatives as cardiotonics
Inventor: SCHNETTLER RICHARD A
IPC: C07D233/90
Filed: 1982-11-03
Granted: 1987-01-22
Abstract: The use of novel imidazolecarboxylic acid derivatives of the following general structure which are useful as antihypertensives, cardiotonics and antithrombotics  <IMAGE>  wherein Q and T are an oxygen or sulfur atom; R is hydrogen, lower alkyl, lower alkylcarbonyl or benzoyl; R1 is hydrogen or -CH(R3)R4; R2 is lower alkoxy, phenoxy or phenoxy substituted at the ortho, meta, or para position with lower alkyl, lower alkoxy, hydroxy, halogen, trifluoromethyl, lower alkylthio, lower alkylsulfone, or lower alkylsulfoxide; R3 is hydrogen or lower alkyl; R4 is hydrogen, hydroxy, lower alkoxy, lower alkylcarbonyl, -ONO2 or halogen; and their pharmaceutically acceptable salts thereof.
Patent AU-771709-B2 (AU)
Title: Corneal surgery device
Inventor: AUFAURE JEAN-LUC
IPC: A61F9/007
Filed: 2001-10-12
Granted: 2004-04-01
Abstract: A device for surgery of the cornea comprising: an annular base ( 100 ) for fixing the apparatus to the eye of a patient; a cutter head ( 200 ) comprising a body ( 200 a) and a blade ( 201 ) suitable for being displaced along a plane trajectory parallel to the annular base ( 100 ); guide means ( 106 ) for guiding the cutter head ( 200 ) relative to the base ( 100 ); drive means ( 302 ) for driving the blade ( 201 ) in the cutter head ( 200 ) with reciprocating linear motion parallel to its cutting edge ( 201 b); and drive means ( 303 ) for driving the cutter head ( 200 ) relative to the annular base ( 100 ) along said trajectory. Said drive means ( 302, 303 ) comprise two independent motor units surmounting the cutter head and having mutually parallel outlet shafts ( 306, 310 ) perpendicular to the plane of the trajectory of the cutter head ( 200 ).